The global immunohistochemistry (IHC) market is poised for significant growth, with an expected value of USD 3.5 billion in 2024. With a projected moderate compound annual growth rate (CAGR) of 7.8%, ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The following is a summary of “Biological characterization and clinical significance of cuproptosis-related genes in lung ...

Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...

Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange ...

Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor ...

USA News Group News Commentary – As the new year begins, the American Association for Cancer Research (AACR) has highlighted ...

Enzo Biochem, Inc. (NYSE: ENZ) ("Enzo" or the "Company") today announced that it was notified by the New York Stock Exchange (the "NYSE") that it is ...

NeoGenomics (NEO – Research Report) received a Hold rating and price target from Benchmark Co. analyst Bruce Jackson today. The company’s ...